Grand Junction and Mesa County · Prescription drugs

Will Colorado's Enbrel Price Cap Cut My Medicare Costs?

Probably not, and not in 2027. Colorado's first-in-the-nation price cap on Enbrel is on hold in federal court. Even if it survives, Medicare got to a lower price first. For a Grand Junction retiree on Enbrel, the number that sets your 2027 bill is the Part D out-of-pocket cap.

Medicare On Main Data Desk

Published October 25, 2026 · 6 min read · Reviewed by Brian Penner, 22+ years in Medicare

What Colorado did, and why it stalled

In fall 2025, Colorado's Prescription Drug Affordability Review Board set what the Colorado Sun called the first state price cap on a prescription drug. It limits how much "a patient or insurer in Colorado will have to pay" for Enbrel, the injectable Amgen drug for rheumatoid arthritis, psoriasis and psoriatic arthritis. The limit is $600 for a standard 50-milligram weekly dose, "about $31,000 per year," starting January 1, 2027. Colorado law says the limit covers every purchase and reimbursement for a drug "dispensed or administered to individuals in the state" (C.R.S. § 10-16-1407).

Amgen sued. On July 2, 2026, pharmaphorum reported that Judge Daniel Domenico of the federal court in Denver granted a preliminary injunction. He wrote that "under binding Federal Circuit precedent, caps on the price of patented drugs like Enbrel are preempted by federal law." The injunction pauses the cap while the lawsuit continues. Courts can change course, so I'm not predicting the final outcome. As of today, though, no Colorado cap is set to take effect January 1.

Medicare got there first

Here's what the headlines left out for people on Medicare. Enbrel was one of the first 10 drugs in Medicare's price negotiation. According to CMS, Medicare's negotiated price went into effect January 1, 2026, at $2,355 for a 30-day supply. That's 67% below the 2023 list price of $7,106. Colorado's board started from that number: its August 2025 draft rule set the cap at $583.59 a unit, "the current Maximum Fair Price for Enbrel." The final rule rounded it up to $600.

Sources: CMS negotiated-price fact sheet (2026); The Colorado Sun (October 7, 2025); pharmaphorum (July 2, 2026). Yearly figures are the 30-day price times 12. CMS can adjust negotiated prices in later years.

Medicare's negotiated price works out to about $28,260 a year, a little below the state cap. So the Colorado limit was built to bring commercial insurance down to roughly what Medicare already pays. The Sun reported that about 60% of Coloradans on Enbrel have private insurance. They're the people the cap was mainly aimed at.

What you'll actually pay for Enbrel in 2027

On Part D, the drug's price matters less than you'd think because your costs are capped. CMS set the 2027 Part D numbers at a $700 standard deductible and a $2,400 out-of-pocket cap. Here's the standard benefit for someone whose only prescription is Enbrel at $2,355 a month:

Illustration using the 2027 defined standard Part D benefit: a $700 deductible, then 25% coinsurance until out-of-pocket costs reach $2,400. Real plans use their own copays and coinsurance, but every plan stops at $2,400. Premiums are separate.

By April you've hit the cap, and the rest of the year is $0 at the pharmacy. At the 2023 list price you'd have reached it in February. A lower price only changes when you reach $2,400, not whether you do. A state cap can't push a Part D member's yearly total below the federal cap. If a big January bill is the problem, the Medicare Prescription Payment Plan spreads it out. Join in January and your bill is at most $200 a month. Our post on lowering drug costs in Grand Junction explains how that works.

Where Grand Junction Enbrel users can still save

Every Part D plan stops at the same $2,400, so the differences are in the plan itself:

• The premium. CMS's 2027 landscape lists 8 stand-alone Part D plans in Colorado. Monthly premiums run from $5.30 to $260.20, which is $63.60 to $3,122.40 a year. Every one of them has the same $2,400 cap. For someone who hits the cap every year, that premium spread can matter more than any change in Enbrel's price.
• Prior authorization. Federal law (42 U.S.C. § 1395w-104) requires every Part D plan to cover drugs with a negotiated price. Coverage doesn't mean no paperwork, though. A new plan may make your doctor re-justify Enbrel. Our post on whether prior authorization carries over covers the transition fill.
• The pharmacy. Specialty drugs often go through a mail-order or specialty pharmacy. Check that the plan's network includes the one you use. How to check a 2027 plan for your drugs walks through it.
• Advantage plans. Mesa County has 10 general Medicare Advantage plans with drug coverage for 2027. Their Part D deductibles run from $300 to $700, and the same $2,400 cap applies. A lower deductible moves costs later in the year but doesn't lower the yearly total for a drug this expensive.

One more point I make with every client on a specialty drug: Medigap doesn't cover prescriptions. If you have Original Medicare with a supplement, your Enbrel goes through your stand-alone Part D plan. That's the one to review this fall.

If the cap comes back

If the courts eventually let Colorado's limit take effect, the biggest change would be for Coloradans on employer and individual coverage. For people on Medicare, both prices are close and the $2,400 cap still sets the yearly total. The effect on premiums, plan formularies and pharmacies would take years to show. I'll update this post if the ruling changes. Until then, plan for 2027 as if the cap doesn't exist, because for Medicare purposes it doesn't yet.

I've been helping people with Medicare for more than 22 years. With a specialty drug, the cost is rarely the surprise. Paperwork, the pharmacy and a premium you didn't need to pay are what catch people. Medicare Open Enrollment runs October 15 to December 7. That's the window to fix any of them for January 1.

How we know all this: the Medicare On Main Data Desk frames every article with public data. Here that means the CMS negotiated-price fact sheet for 2026; The Colorado Sun's October 7, 2025 report on the upper payment limit; the Colorado Division of Insurance draft rule; pharmaphorum's July 2, 2026 report on the federal injunction; C.R.S. § 10-16-1407; 42 U.S.C. § 1395w-104; the CMS 2027 Rate Announcement; and CMS's 2027 Medicare Advantage and Part D landscape files, all read October 25, 2026. Court cases can change quickly, so check for updates before relying on the status of the cap. Medicare On Main is not affiliated with Amgen or the State of Colorado, and carrier and drug names are factual reporting, not endorsement. This is education, not legal, tax or medical advice. Ask your doctor about your treatment and compare plans with a licensed agent. We take no payment from any carrier to feature a plan.